A Human Immunodeficiency Virus Superinfection Diagnosed in a Patient on Intramuscular Long-acting Combination of Cabotegravir and Rilpivirine

A case of a male with human immunodeficiency virus with plasma genotyping detecting no resistance and a CRF02_AG subtype had a controlled HIV RNA on antiretroviral therapy since 2010. We introduced intramuscular therapy with cabotegravir and rilpivirine. One month later, his HIV RNA was 1500 copies/mL; genotyping found a subtype B with many mutations. Graphical Abstract https://tidbitapp.io/tidbits/an-hiv-superinfection-diagnosed-in-a-patient-on-intramuscular-long-acting-combination-of-cabotegravir-and-rilpivirine-94dc0209-2685-44da-b267-9649a59815f9